Dalton G R, Jones J V, Levi A J, Levy A
Department of Physiology, School of Medical Sciences, University of Bristol, UK.
J Hypertens. 2000 Sep;18(9):1297-306. doi: 10.1097/00004872-200018090-00016.
Left ventricular hypertrophy (LVH) is present in young spontaneously hypertensive rats (SHR) compared with normotensive Wistar-Kyoto (WKY) rats and treatment of SHR with captopril leads to regression of LVH. Hypertrophy produces changes in gene expression for myofibrillar proteins with increased ratios of skeletal to cardiac actin and beta to alpha-myosin heavy chain (MHC).
The objective of this study was to follow changes in transcript prevalence for these four proteins during ageing and with captopril treatment in SHR and WKY rats.
Untreated SHR and WKY rats were studied at 100, 156, 350 and 450 days. Groups at 100 and 350 days were divided into a treatment group (given captopril) and untreated controls. Transcripts were measured using in situ hybridization.
Both cardiac and skeletal actin were increased in untreated SHR compared to WKY rats (P<0.01 and P<0.05, respectively). alpha-MHC was increased (P<0.01) whilst beta-MHC was normal in 100-day-old SHR (an age when LVH was present) compared with WKY rats. With ageing, alpha-MHC declined and beta-MHC increased giving the increased ratio of beta to alpha-MHC transcripts reported by other investigators. Treatment of SHR led to a significant decline in skeletal actin transcripts (P< 0.01) and reversed the rise in beta-MHC expression that occurred with ageing (P< 0.01).
LVH in SHR is associated with increased skeletal and cardiac actin transcripts. Despite unequivocal LVH in SHR at 100 days of age, alpha rather than beta-MHC transcripts were increased. Only with ageing did the classically reported increased ratio of beta to alpha-MHC transcripts become apparent Captopril treatment reduced skeletal actin transcripts and reversed the increase in beta-MHC that occurred with ageing.
与血压正常的Wistar - Kyoto(WKY)大鼠相比,年轻的自发性高血压大鼠(SHR)存在左心室肥厚(LVH),用卡托普利治疗SHR可使LVH消退。肥厚会导致肌原纤维蛋白的基因表达发生变化,骨骼肌动蛋白与心肌肌动蛋白以及β-肌球蛋白重链(MHC)与α-肌球蛋白重链的比例增加。
本研究的目的是追踪这四种蛋白质的转录本丰度在衰老过程中以及在SHR和WKY大鼠中接受卡托普利治疗后的变化。
对未经治疗的SHR和WKY大鼠在100、156、350和450日龄时进行研究。100日龄和350日龄的组分为治疗组(给予卡托普利)和未治疗的对照组。使用原位杂交法测量转录本。
与WKY大鼠相比,未经治疗的SHR中心肌和骨骼肌肌动蛋白均增加(分别为P<0.01和P<0.05)。与WKY大鼠相比,100日龄的SHR(此时存在LVH)中α-MHC增加(P<0.01),而β-MHC正常。随着年龄增长,α-MHC下降,β-MHC增加,导致其他研究者报道的β与α-MHC转录本比例增加。SHR的治疗导致骨骼肌肌动蛋白转录本显著下降(P<0.01),并逆转了随着年龄增长而出现的β-MHC表达升高(P<0.01)。
SHR中的LVH与骨骼肌和心肌肌动蛋白转录本增加有关。尽管100日龄的SHR中LVH明确,但α-MHC转录本而非β-MHC转录本增加。只有随着年龄增长,经典报道的β与α-MHC转录本比例增加才变得明显。卡托普利治疗减少了骨骼肌肌动蛋白转录本,并逆转了随着年龄增长而出现的β-MHC增加。